High Doses of Candesartan Cilexetil on the Reduction of Proteinuria
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of high doses of candesartan cilexetil and
also to assess which dose (16mg, 64mg, 128mg) is the most optimal for the maximum reduction
of proteinuria.